ArticleInternational journal of molecular sciences2026
The Role of ULK3 in Cancer Progression: A Pan-Cancer Bioinformatics Analysis Integrated with Experimental Validation in Prostate Cancer.
Yangyang Han, Mengqi Zhang, Mannizire Rehemujiang, Xintong Li, Yimin Liu, Niuniu Zhang, Meng Sun, Yunbo Zhang, Ayshamgul Hasim, Mengjia Li
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Yangyang HanDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.ORCID 0009-0005-9284-5530 Mengqi ZhangDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Mannizire RehemujiangDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Xintong LiDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Yimin LiuDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Niuniu ZhangDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Meng SunDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Yunbo ZhangDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.
Ayshamgul HasimXinjiang Key Laboratory of Molecular Biology for Endemic Diseases, Xinjiang Medical University, Urumqi 830017, China.
Mengjia LiDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi 830017, China.ORCID 0000-0002-2767-9266 Funding
National Natural Science Foundation of China 32300465National Natural Science Foundation of China 82260493Open Research Fund Project of Key Laboratory of High Incidence Disease Research in Xinjiang，Ministry of Education 2025B02Xinjiang Key Laboratory of Molecular Biology for Endemic Diseases XJDFB2024G02
6 · The paper itselfAbstract
Unc-51-like kinase 3 (ULK3) is a key member of the ULK serine/threonine kinase family. Aberrant
Indexed as
Computational BiologyProstatic NeoplasmsProtein Serine-Threonine KinasesBiomarkers, TumorCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticHumansMalePrognosisBiomarkers, TumorProtein Serine-Threonine Kinasesimmunitypan-cancerprognostic biomarkersprostate cancerULK3
Identifiers
PMID42450307
PMCPMC13361878
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390